Monsanto is an American agricultural biotechnology corporation, second largest producer of genetic products.

The company published its annual guidance for fiscal 2012 on May 30th. Due to a third quarter higher than expected and a strong performance of global seeds market, Monsanto expects earnings per share in a range between USD 3.65 and USD 3.70 up to its last estimation at USD 3.49. Analysts are confident and Thomson-Reuters consensus focus on an average target price at USD 86.3.

The share has hardly penalized in the past 2 months, but at contact with USD 69.90 short-term support, is set up a technical rebound, and the stock recovered more than 10% during last few sessions. The today's bullish gap has allowed to stock to over pass the moving average 50 days. The bullish trend is able to continue on the way to the USD 83.4 levels.

Investors could take a buying position on the stock with an objective at USD 83.4. A stop loss will avoid disappointment below 20-days moving average, corresponding to an opened gap at USD 71.5.